These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 1490825)

  • 1. Dose dependent induction of CYP1A2 activity by omeprazole (Antra).
    Rost KL; Brösicke H; Scheffler M; Roots I
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):542-3. PubMed ID: 1490825
    [No Abstract]   [Full Text] [Related]  

  • 2. Specific and dose-dependent enzyme induction by omeprazole in human beings.
    Rost KL; Brösicke H; Heinemeyer G; Roots I
    Hepatology; 1994 Nov; 20(5):1204-12. PubMed ID: 7927253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase of cytochrome P450IA2 activity by omeprazole: evidence by the 13C-[N-3-methyl]-caffeine breath test in poor and extensive metabolizers of S-mephenytoin.
    Rost KL; Brösicke H; Brockmöller J; Scheffler M; Helge H; Roots I
    Clin Pharmacol Ther; 1992 Aug; 52(2):170-80. PubMed ID: 1505152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P450IA2 and omeprazole.
    Farrell G
    Gastroenterology; 1992 May; 102(5):1822-3. PubMed ID: 1345326
    [No Abstract]   [Full Text] [Related]  

  • 5. Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats.
    Chen L; Bondoc FY; Lee MJ; Hussin AH; Thomas PE; Yang CS
    Drug Metab Dispos; 1996 May; 24(5):529-33. PubMed ID: 8723732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omeprazole induction of cytochrome P-450IA2: the importance of selecting the appropriate human model.
    Watkins PB
    Hepatology; 1993 Apr; 17(4):748-50. PubMed ID: 8477980
    [No Abstract]   [Full Text] [Related]  

  • 7. Omeprazole does not enhance the metabolism of phenacetin, a marker of CYP1A2 activity, in healthy volunteers.
    Xiaodong S; Gatti G; Bartoli A; Cipolla G; Crema F; Perucca E
    Ther Drug Monit; 1994 Jun; 16(3):248-50. PubMed ID: 8085279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of CYP2E1 and CYP1A2 activity as a function of acetaminophen dose: relation to toxicity.
    Snawder JE; Roe AL; Benson RW; Roberts DW
    Biochem Biophys Res Commun; 1994 Aug; 203(1):532-9. PubMed ID: 8074700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Omeprazole and the cytochrome P450 system of the liver].
    Petersen KU
    Leber Magen Darm; 1993 Sep; 23(5):186-92. PubMed ID: 8412467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-week treatment with omeprazole increases the metabolism of caffeine.
    Nousbaum JB; Berthou F; Carlhant D; Riche C; Robaszkiewicz M; Gouerou H
    Am J Gastroenterol; 1994 Mar; 89(3):371-5. PubMed ID: 8122647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
    Curi-Pedrosa R; Daujat M; Pichard L; Ourlin JC; Clair P; Gervot L; Lesca P; Domergue J; Joyeux H; Fourtanier G
    J Pharmacol Exp Ther; 1994 Apr; 269(1):384-92. PubMed ID: 8169844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subchronic dietary exposure to Aroclor 1254 in rats: accumulation of PCBs in liver, blood, and adipose tissue and its relationship to induction of various hepatic drug-metabolizing enzymes.
    Dragnev KH; Beebe LE; Jones CR; Fox SD; Thomas PE; Nims RW; Lubet RA
    Toxicol Appl Pharmacol; 1994 Mar; 125(1):111-22. PubMed ID: 7510429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P4501A2 activity in humans.
    Sinha R; Rothman N; Brown ED; Mark SD; Hoover RN; Caporaso NE; Levander OA; Knize MG; Lang NP; Kadlubar FF
    Cancer Res; 1994 Dec; 54(23):6154-9. PubMed ID: 7954461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta 1 down-regulates basal and polycyclic aromatic hydrocarbon-induced cytochromes P-450 1A1 and 1A2 in adult human hepatocytes in primary culture.
    Abdel-Razzak Z; Corcos L; Fautrel A; Campion JP; Guillouzo A
    Mol Pharmacol; 1994 Dec; 46(6):1100-10. PubMed ID: 7808430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of mebendazole on P4501A activity in rat hepatocytes and HepG2 cells. Comparison with tiabendazole and omeprazole.
    Baliharová V; Skálová L; Maas RF; De Vrieze G; Bull S; Fink-Gremmels J
    J Pharm Pharmacol; 2003 Jun; 55(6):773-81. PubMed ID: 12841937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test.
    Rost KL; Roots I
    Clin Pharmacol Ther; 1994 Apr; 55(4):402-11. PubMed ID: 8162667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucuronosyltransferase in biopsies of human duodenal mucosa.
    Buchthal J; Grund KE; Buchmann A; Schrenk D; Beaune P; Bock KW
    Eur J Clin Pharmacol; 1995; 47(5):431-5. PubMed ID: 7720765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP1A2 and 2E1 expression in rat liver treated with combined inducers (3-methylcholanthrene and ethanol).
    Goasduff T; Menez JF; Dreano Y; Berthou F
    Biochem Biophys Res Commun; 1995 Jun; 211(2):497-503. PubMed ID: 7794261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omeprazole transactivates human CYP1A1 and CYP1A2 expression through the common regulatory region containing multiple xenobiotic-responsive elements.
    Yoshinari K; Ueda R; Kusano K; Yoshimura T; Nagata K; Yamazoe Y
    Biochem Pharmacol; 2008 Jul; 76(1):139-45. PubMed ID: 18502397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytochrome P450 induction by rifampicin in healthy subjects: determination using the Karolinska cocktail and the endogenous CYP3A4 marker 4beta-hydroxycholesterol.
    Kanebratt KP; Diczfalusy U; Bäckström T; Sparve E; Bredberg E; Böttiger Y; Andersson TB; Bertilsson L
    Clin Pharmacol Ther; 2008 Nov; 84(5):589-94. PubMed ID: 18650803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.